Amy Degnim, M.D., receives R-01 research grant

Amy Degnim, M.D. (S ’03), Division of Breast, Endocrine, Metabolic, and Gastrointestinal Surgery at Mayo Clinic in Rochester, was awarded an R-01 research grant for “Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia.”

She and her team will pursue translational research to improve breast cancer prevention in women at high risk due to atypical hyperplasia. They will develop a NanoString assay to refine individualized breast cancer risk prediction, develop biomarkers of beneficial response to tamoxifen for prevention, and identify novel early biomarkers of individualized response to prevention therapy.

Dr. Degnim is a professor of surgery in the Mayo Clinic College of Medicine and Science.

Recommended reading

Posts about similar topics: